London
· Delayed Price · Currency is GBP · Price in USD Tandem Diabetes Care Statistics
Total Valuation
LON:0M0F has a market cap or net worth of GBP 1.02 billion. The enterprise value is 1.12 billion.
| Market Cap | 1.02B |
| Enterprise Value | 1.12B |
Important Dates
The last earnings date was Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 66.61M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.86% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 61.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.35 |
| PB Ratio | 8.52 |
| P/TBV Ratio | 8.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.87 |
| EV / Sales | 1.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -381.31 |
Financial Position
The company has a current ratio of 2.30, with a Debt / Equity ratio of 3.21.
| Current Ratio | 2.30 |
| Quick Ratio | 1.72 |
| Debt / Equity | 3.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | -131.22 |
| Interest Coverage | -12.46 |
Financial Efficiency
Return on equity (ROE) is -92.31% and return on invested capital (ROIC) is -8.36%.
| Return on Equity (ROE) | -92.31% |
| Return on Assets (ROA) | -6.17% |
| Return on Invested Capital (ROIC) | -8.36% |
| Return on Capital Employed (ROCE) | -14.50% |
| Revenue Per Employee | 287,092 |
| Profits Per Employee | -53,702 |
| Employee Count | 2,650 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 3.18 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.55% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -53.55% |
| 50-Day Moving Average | 19.50 |
| 200-Day Moving Average | 31.69 |
| Relative Strength Index (RSI) | 46.96 |
| Average Volume (20 Days) | 570 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.60 |
Income Statement
In the last 12 months, LON:0M0F had revenue of GBP 760.79 million and -142.31 million in losses. Loss per share was -2.17.
| Revenue | 760.79M |
| Gross Profit | 397.30M |
| Operating Income | -71.16M |
| Pretax Income | -135.01M |
| Net Income | -142.31M |
| EBITDA | -58.10M |
| EBIT | -71.16M |
| Loss Per Share | -2.17 |
Balance Sheet
The company has 285.31 million in cash and 385.53 million in debt, giving a net cash position of -100.21 million.
| Cash & Cash Equivalents | 285.31M |
| Total Debt | 385.53M |
| Net Cash | -100.21M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 120.19M |
| Book Value Per Share | 1.81 |
| Working Capital | 290.45M |
Cash Flow
In the last 12 months, operating cash flow was 10.79 million and capital expenditures -13.73 million, giving a free cash flow of -2.94 million.
| Operating Cash Flow | 10.79M |
| Capital Expenditures | -13.73M |
| Free Cash Flow | -2.94M |
| FCF Per Share | n/a |
Margins
Gross margin is 52.22%, with operating and profit margins of -9.35% and -18.71%.
| Gross Margin | 52.22% |
| Operating Margin | -9.35% |
| Pretax Margin | -17.75% |
| Profit Margin | -18.71% |
| EBITDA Margin | -7.64% |
| EBIT Margin | -9.35% |
| FCF Margin | n/a |
Dividends & Yields
LON:0M0F does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.86% |
| Shareholder Yield | n/a |
| Earnings Yield | -13.90% |
| FCF Yield | -0.29% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0M0F has an Altman Z-Score of 1.32. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.32 |
| Piotroski F-Score | n/a |